Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19191 | 28329615 | Dermatol Online J | Necrolytic migratory erythema associated with fatty liver disease and the psuedoglucagonoma syndrome. | 2016 | Details |
| A19202 | 26707008 | Liver Transpl | Prevalence and risk factors of steatosis after liver transplantation and patient outcomes. | 2016 | Details |
| A19205 | 26703429 | Eur J Intern Med | Uric acid in metabolic syndrome: From an innocent bystander to a central player. | 2015 | Details |
| A19207 | 26703125 | Dig Dis Sci | Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review. | 2015 | Details |
| A19244 | 26675585 | BBA Clin | Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients. | 2014 | Details |
| A19245 | 26675364 | World J Gastroenterol | Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. | 2015 | Details |
| A19262 | 26667615 | Vnitr Lek | [Approach to patients with liver diseases]. | 2015 | Details |
| A19263 | 26667191 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. | 2016 | Details |
| A19269 | 26666336 | BMC Gastroenterol | Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis. | 2015 | Details |
| A19277 | 26660688 | Obes Surg | Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients. | 2016 | Details |
| A19285 | 26652175 | BMC Gastroenterol | Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. | 2015 | Details |
| A19292 | 26645107 | J Cell Mol Med | Role of stem cells during diabetic liver injury. | 2015 | Details |
| A19319 | 26631018 | Lipids Health Dis | Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. | 2015 | Details |
| A19323 | 26629547 | EBioMedicine | Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals. | 2015 | Details |
| A19342 | 26620035 | Mymensingh Med J | Non-alcoholic Fatty Liver Disease (NAFLD)--A Review. | 2015 | Details |
| A19351 | 26613006 | Diabetol Metab Syndr | The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study. | 2015 | Details |
| A19357 | 26609343 | World J Hepatol | Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. | 2015 | Details |
| A19360 | 26608256 | Lancet | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. | 2015 | Details |
| A19379 | 26599361 | PLoS One | Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study. | 2015 | Details |
| A19382 | 26598837 | J Nutr Sci Vitaminol (Tokyo) | Lipid Nutrition and Healthy Aging. | 2015 | Details |
| A19384 | 26597657 | Obes Rev | Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review. | 2015 | Details |
| A19388 | 26594248 | Diabetol Metab Syndr | Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus. | 2015 | Details |
| A19401 | 26591121 | J Assoc Physicians India | Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome. | 2015 | Details |
| A19404 | 26589371 | Arab J Gastroenterol | Essential phospholipids as a supportive adjunct in the management of patients with NAFLD. | 2015 | Details |
| A19418 | 26580649 | Nutrients | The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis. | 2015 | Details |
| A19420 | 26576787 | J Med Ultrason (2001) | Usefulness of ultrasonographic estimation of preperitoneal and subcutaneous fat thickness in the diagnosis of nonalcoholic fatty liver disease in diabetic patients. | 2015 | Details |
| A19426 | 26573193 | Zhonghua Gan Zang Bing Za Zhi | [Relationship of socioeconomic status and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus]. | 2015 | Details |
| A19427 | 26573192 | Zhonghua Gan Zang Bing Za Zhi | [Body mass index is a risk factor for new-onset non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus]. | 2015 | Details |
| A19446 | 26566287 | PLoS One | Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. | 2015 | Details |
| A19458 | 26557954 | World J Hepatol | Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A19468 | 26547840 | BMC Complement Altern Med | Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea. | 2015 | Details |
| A19469 | 26547273 | Med Hypotheses | Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia. | 2015 | Details |
| A19476 | 26537487 | Dig Dis Sci | Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record. | 2015 | Details |
| A19479 | 26536609 | J Magn Reson Imaging | MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes. | 2015 | Details |
| A19488 | 26525342 | Physiology (Bethesda) | Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism. | 2015 | Details |
| A19492 | 26524361 | Zhonghua Gan Zang Bing Za Zhi | [Relationship between non-alcoholic fatty liver disease and incidence of type 2 diabetes mellitus in Chinese adults: a prospective cohort study]. | 2015 | Details |
| A19503 | 26517932 | Biochem Soc Trans | The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations. | 2015 | Details |
| A19522 | 26511621 | Cardiovasc Diabetol | Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk. | 2015 | Details |
| A19527 | 26509555 | Liver Int | Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study. | 2015 | Details |
| A19528 | 26508982 | Evid Based Complement Alternat Med | Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo. | 2015 | Details |
| A19547 | 26494963 | World J Gastroenterol | Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. | 2015 | Details |
| A19560 | 26485614 | Endocrinology | The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice. | 2015 | Details |
| A19564 | 26483372 | Georgian Med News | [C677T AND A1298C ALLELE POLYMORPHISM GENE OF METHYLENETETRAHYDRAFOLATEREDUCTASE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES]. | 2015 | Details |
| A19572 | 26476631 | Eur J Nutr | A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. | 2016 | Details |
| A19575 | 26475841 | Perit Dial Int | Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients. | 2015 | Details |
| A19592 | 26468154 | Curr Diab Rep | Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin. | 2015 | Details |
| A19594 | 26464753 | World J Hepatol | Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. | 2015 | Details |
| A19601 | 26462866 | Diabetes Obes Metab | Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis. | 2015 | Details |
| A19618 | 26454786 | Dig Liver Dis | Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. | 2015 | Details |
| A19619 | 26454513 | QJM | Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. | 2015 | Details |
| A19642 | 26441288 | Aten Primaria | [Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care]. | 2015 | Details |
| A19656 | 26433207 | Diabet Med | Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. | 2015 | Details |
| A19659 | 26431876 | Biochem Biophys Res Commun | Hepatic scavenger receptor BI is associated with type 2 diabetes but unrelated to human and murine non-alcoholic fatty liver disease. | 2015 | Details |
| A19669 | 26425466 | Indian J Endocrinol Metab | Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. | 2015 | Details |
| A19672 | 26423094 | J Endocrinol | Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. | 2015 | Details |
| A19684 | 26412465 | Curr Pharm Des | Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome. | 2015 | Details |
| A19685 | 26411937 | Nihon Eiseigaku Zasshi | [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis]. | 2015 | Details |
| A19693 | 26406351 | J Dig Dis | Nonalcoholic fatty liver disease - current status and future directions. | 2015 | Details |
| A19713 | 26398456 | Eur J Gastroenterol Hepatol | Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus. | 2015 | Details |
| A19724 | 26394261 | Appl Physiol Nutr Metab | Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats. | 2015 | Details |
| A19739 | 26381272 | Diabetes Metab Res Rev | Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies. | 2015 | Details |
| A19752 | 26378641 | Semin Liver Dis | Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander. | 2015 | Details |
| A19762 | 26369383 | Aliment Pharmacol Ther | Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. | 2015 | Details |
| A19768 | 26363598 | Curr Diab Rep | Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Obesity-Related Traits. | 2015 | Details |
| A19775 | 26357637 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy. | 2015 | Details |
| A19778 | 26356325 | J Clin Transl Hepatol | Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases. | 2015 | Details |
| A19792 | 26347179 | Cell Biochem Funct | Changes in glucose transporter expression and nitric oxide production are associated with liver injury in diabetes. | 2015 | Details |
| A19798 | 26343077 | Med Ultrason | Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A19801 | 26341826 | J Hepatol | Hepatocellular carcinoma and lifestyles. | 2015 | Details |
| A19806 | 26339423 | Int J Clin Exp Pathol | Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19815 | 26330344 | Am J Physiol Endocrinol Metab | Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. | 2015 | Details |
| A19819 | 26328027 | World J Hepatol | Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. | 2015 | Details |
| A19821 | 26327768 | World J Gastroenterol | Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. | 2015 | Details |
| A19824 | 26325428 | Biochem Biophys Res Commun | Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity. | 2015 | Details |
| A19840 | 26315331 | Diabet Med | Diabetic hepatosclerosis: another diabetes microvascular complication? | 2016 | Details |
| A19849 | 28943619 | Diseases | MOGAT2: A New Therapeutic Target for Metabolic Syndrome. | 2015 | Details |
| A19852 | 26305052 | Biochem Cell Biol | Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol. | 2015 | Details |
| A19855 | 26303223 | Prim Care Diabetes | Analysis of the Japanese Diabetes Risk Score and fatty liver markers for incident diabetes in a Japanese cohort. | 2015 | Details |
| A19868 | 26297218 | J Diabetes Complications | An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes. | 2015 | Details |
| A19875 | 26290633 | World J Gastroenterol | Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions. | 2015 | Details |
| A19878 | 26289505 | Niger J Clin Pract | Nonalcoholic fatty liver disease: Synopsis of current developments. | 2016 | Details |
| A19883 | 26285328 | Vopr Kurortol Fizioter Lech Fiz Kult | [The effectiveness of the spa and health resort-based treatment with the application of Essentuki-type drinking mineral waters for the management of non-alcoholic fatty liver disease in the patients presenting with type 2 diabetes mellitus]. | 2015 | Details |
| A19900 | 26278350 | Diabetes Res Clin Pract | Country of birth modifies the association of fatty liver index with insulin action in Middle Eastern immigrants to Sweden. | 2015 | Details |
| A19901 | 26276551 | BMC Endocr Disord | Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. | 2015 | Details |
| A19916 | 26269698 | Case Rep Gastroenterol | Glycogenic Hepatopathy: Thinking Outside the Box. | 2015 | Details |
| A19917 | 26269440 | Zhonghua Nei Ke Za Zhi | [The impact of non-alcoholic fatty liver disease on islet function in type 2 diabetes]. | 2015 | Details |
| A19918 | 26269425 | Sci Rep | Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort. | 2015 | Details |
| A19921 | 26264980 | J Endocrinol | Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity. | 2015 | Details |
| A19930 | 26258810 | Eur J Cancer Prev | Pentoxifylline prevents nonalcoholic steatohepatitis-related liver pre-neoplasms by inhibiting hepatic inflammation and lipogenesis. | 2016 | Details |
| A19931 | 26256971 | Yonsei Med J | Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis. | 2015 | Details |
| A19941 | 26252899 | PLoS One | Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes. | 2015 | Details |
| A19945 | 26250831 | Dig Dis Sci | Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. | 2015 | Details |
| A19947 | 26250514 | Obesity (Silver Spring) | Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. | 2015 | Details |
| A19948 | 26247669 | Clinics (Sao Paulo) | Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study. | 2015 | Details |
| A19956 | 26242131 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [The New Idea about Early Intervention for Type 2 Diabetes Based on Gan Disease Transferring to Pi in Metabolic Diseases]. | 2015 | Details |
| A19958 | 26240695 | World J Diabetes | Metabolic surgery: A paradigm shift in type 2 diabetes management. | 2015 | Details |
| A19968 | 26234526 | Br J Nutr | The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. | 2015 | Details |
| A19973 | 26232233 | Am J Physiol Heart Circ Physiol | Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. | 2015 | Details |
| A19975 | 26229968 | J Diabetes Res | Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints. | 2015 | Details |
| A19978 | 26228676 | J Clin Lipidol | Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. | 2015 | Details |